Certain foods and nutrients were found to influence the risk of developing liver cancer. For example, aflatoxins (toxins from ...

A new study has established that the follow-up of the fatty liver index (FLI), both baseline and longitudinally, is an ...

Over 80% of hepatocellular carcinoma (HCC) – the third-leading cause of cancer deaths globally – emerges from advanced liver fibrosis or cirrhosis. A comprehensive review in Hepatology International ...

Due to the increasing rate of obesity, cases of liver cancer are expected to double by 2050. This claim has been made in a ...

More than 500,000 annual liver cancer diagnoses could be prevented with global interventions aimed at reducing viral hepatitis B and C, alcohol consumption and a disease strongly associated with ...

Domestic researchers have found for the first time in the world that immuno-cancer drugs atetzolizumab plus bevacizumab ...

The liver is the largest internal organ of the human body. This vital organ is crucial for the processes of digestion, ...

Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment ...

Hepatitis B vaccination stands as a powerful tool against liver cancer, particularly hepatocellular carcinoma, by preventing ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

This review explores the dynamic landscape of hepatocellular carcinoma (HCC) treatment, emphasizing on recent developments across various stages and therapeutic approaches. Although curative ...

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the fourth most common cause of cancer-related death worldwide. 1 In 2017, there were an estimated 953,000 incident cases of liver ...